An observational study to find the effects of anti diabetic medications on bone turnover markers and fracture risk in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2019/04/018599
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with type 2 diabetes mellitus, attending the out-patient and in-patient services of Medicine department prescribed with Metformin or Metformin in combination with DPP-4 inhibitor-Teneligliptin, SGLT2 inhibitor-Empagliflozin who are willing to participate in the study will be enrolled from baseline to 3 months followup.
Exclusion Criteria
Patients with chronic alcoholism and smoking/tobacco use
Patients with primary and secondary causes of bone loss
Patients who are on medications that may affect bone metabolism
Patients who are not willing to participate in the study, mentally challenged and unconscious patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method